Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history

Ratios

vs
industry
vs
history
P/E(ttm) 26.90
IHE's P/E(ttm) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IHE: 26.90 )
Ranked among companies with meaningful P/E(ttm) only.
IHE' s P/E(ttm) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 28.37
Current: 26.9
0
28.37
PE(NRI) 26.90
IHE's PE(NRI) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IHE: 26.90 )
Ranked among companies with meaningful PE(NRI) only.
IHE' s PE(NRI) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 28.37
Current: 26.9
0
28.37
P/B 2.79
IHE's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IHE: 2.79 )
Ranked among companies with meaningful P/B only.
IHE' s P/B Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 3.01
Current: 2.79
0
3.01

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.15
IHE's Dividend Yield is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IHE: 1.15 )
Ranked among companies with meaningful Dividend Yield only.
IHE' s Dividend Yield Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 1.13
Current: 1.15
0
1.13
Yield on cost (5-Year) 1.13
IHE's Yield on cost (5-Year) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IHE: 1.13 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
IHE' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 1.13
Current: 1.13
0
1.13

More Statistics

Short Percentage of Float0.00%
52-Week Range $131.71 - 181.41
Shares Outstanding(Mil)6950000.00
» More Articles for IHE

Headlines

Articles On GuruFocus.com
Columbia Wanger Sells Out 3 Stakes in Portfolio May 05 2016 
Doom, Gloom and Champagne May 05 2016 
Economic Data Continues to Be Weak May 05 2016 
Infinera's CEO Buys Company Shares May 05 2016 
Royce Funds Commentary: The Economy's Journey into Uncharted Waters May 05 2016 
The Art of Speculation May 05 2016 
Matthews China Fund Buys Stake in Alibaba May 05 2016 
Oracle of Omaha Reduces Stake in VeriSign May 05 2016 
Yacktman Funds Comments on Coca-Cola May 04 2016 
Yacktman Funds Comments on 21st Century Fox May 04 2016 

More From Other Websites
Pharma ETFs Outlook -- Drug Pricing Issues Remain in Focus May 04 2016
Finding Pharmaceuticals ETFs With Rebound Potential May 04 2016
The Last Week of April Wasn’t Good for Biotechnology Stocks May 02 2016
Fertilizer Impact: Natural Gas Prices Rise Yet Again for Week Ending April 22 Apr 28 2016
A Segment-by-Segment Breakdown of JNJ’s 1Q16 Earnings Apr 25 2016
5 Best Performing Bull Run Equity ETFs Mar 09 2016
Drug Patent Expirations: $190 Billion Is Up for Grabs Mar 03 2016
Other Industries That Depend on Specialty Chemicals—and Why Mar 02 2016
Look Beyond Pharma to Opportunities in Generics! Mar 01 2016
What Does 2016 Hold in Store for Pharma ETFs Jan 04 2016
How Will Johnson & Johnson’s Pharmaceutical Segment Do in 4Q15? Dec 31 2015
IYZ Sees $57.2 Million in Fund Outflows in Trailing 12 Months Dec 29 2015
IYZ Sees $59.3 Million in Fund Inflows in Trailing 12 Months Dec 17 2015
The iShares US Medical Devices ETF (IHI) Has Put Nothing under the Tree in December—Yet Dec 16 2015
IYW Sees $61.7 Billion in Fund Inflows in Trailing 1 Month Dec 11 2015
Pfizer in Talks to Buy Allergan: Prescribed ETFs Nov 19 2015
Don't Abandon Preferred ETFs Nov 09 2015
Crude Oil Rig Count: Will It Fuel Optimism in the Crude Oil Market? Nov 06 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK